EP3310331
Inndælanlegar lyfjablöndur af lefamúlíni
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
14.6.2016EP published:
14.10.2020EP application number:
16729258.0
EP translation filed:
16.12.2020Grant published:
15.1.2021EPO information:
European Patent Register
Max expiry date:
13.6.2036Expiry date:
13.6.2026Next due date:
30.6.2026
Title:
INJECTABLE PHARMACEUTICAL FORMULATIONS OF LEFAMULIN
Timeline
Today
14.6.2016EP application
14.10.2020EP Publication
16.12.2020Translation submitted
15.1.2021Registration published
13.6.2026Expires
Owner
Name:
Nabriva Therapeutics GMBHAddress:
Leberstraße 20, 1110 Wien, AT
Inventor
Name:
FERENCIC, MathiasAddress:
3400 Klosterneuburg, AT
Name:
HEILMAYER, WernerAddress:
7034 Zillingtal, AT
Name:
HINSMANN, PeterAddress:
1030 Wien, AT
Name:
WICHA, WolfgangAddress:
2460 Bruck an der Leitha, AT
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201562180871 PDate:
17.6.2015Country:
US
Classification
Categories:
A61K 9/00, A61K 47/02, A61K 9/08, A61K 31/215, A61P 31/04
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 16.6.2021
Expires: 13.6.2022
Payer: Patice ehf.
Number: 7
Paid: 16.6.2022
Expires: 13.6.2023
Payer: Patice ehf.
Number: 8
Paid: 21.6.2023
Expires: 13.6.2024
Payer: Árnason Faktor ehf.
Number: 9
Paid: 22.11.2024
Expires: 13.6.2025
Payer: Árnason Faktor ehf.
Number: 10
Paid: 4.6.2025
Expires: 13.6.2026
Payer: Árnason Faktor ehf.